Sign in

CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company

Phio Pharmaceuticals Corp.

Sign in to watch
Ticker
PHIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
453215903
Phone
(508) 767-3861
Business address
411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
Former names
RXi Pharmaceuticals Corp
Open-market buys, last 90 days
$104,806
in 9 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$104,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 55 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-08-01 Dispersyn Gerrit Chief Development Officer Grant or award · Stock option (right to buy) +16,000 16,000
2018-08-01 Kontulis Caitlin Secretary & Dir. of Finance Grant or award +10,500 11,024
2018-08-01 Kontulis Caitlin Secretary & Dir. of Finance Grant or award · Stock option (right to buy) +10,500 10,500
2017-10-02 CAUWENBERGH GEERT President & CEO Purchase +2,700 $0.44 $1K 135,283
2017-10-02 CAUWENBERGH GEERT President & CEO Purchase +200 $0.46 $92 135,483
2017-10-02 CAUWENBERGH GEERT President & CEO Purchase +7,100 $0.45 $3K 142,583
2017-09-07 Eliseev Alexey Chief Business Officer Sale −58,712 $0.53 $31K 950,312
2017-09-06 Eliseev Alexey Chief Business Officer Sale −91,907 $0.54 $49K 1,009,024
2017-09-05 Eliseev Alexey Chief Business Officer Sale −26,181 $0.56 $15K 1,100,931
2017-09-01 Eliseev Alexey Chief Business Officer Sale −23,200 $0.57 $13K 1,127,112
2017-08-24 CAUWENBERGH GEERT President & CEO Purchase +4,900 $0.55 $3K 127,483
2017-08-24 CAUWENBERGH GEERT President & CEO Purchase +4,361 $0.55 $2K 131,844
2017-08-24 CAUWENBERGH GEERT President & CEO Purchase +739 $0.56 $414 132,583
2017-06-23 Dispersyn Gerrit Chief Development Officer Purchase +3,500 $0.62 $2K 3,500
2017-06-22 CAUWENBERGH GEERT President & CEO Purchase +5,000 $0.63 $3K 117,583
2017-06-22 CAUWENBERGH GEERT President & CEO Purchase +5,000 $0.62 $3K 122,583
2017-06-09 Eliseev Alexey Chief Business Officer Conversion +332,499 1,150,312
2017-06-09 Eliseev Alexey Chief Business Officer Conversion · Series C Convertible Preferred Stock, $0.0001 par value −332,499 0
2017-06-06 Freeman Jonathan E Director Grant or award · Stock option (right to buy) +3,500 3,500
2017-04-26 CAUWENBERGH GEERT President & CEO Purchase +10,000 $0.65 $6K 112,583

Page 8 of 13 · 258 trades